Skip to main content
OpenTrials

Clinical trial condition

Liver Neoplasms

Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.

1,743 public trials 464 recruiting studies
Refine in advanced search Browse all conditions

Liver Neoplasms trial results

Completed

IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients

NCT03203005

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Universitair Ziekenhuis Antwerpen (UZA), Division of Gastroenterology and Hepatology Edegem, Belgium
  • Universitätsklinik für Allgemeine, Viszeral- und Transplantationschirurgie Tübingen, Germany
  • Istituto Nazionale Tumori "Pascale" (INTNA) Naples, Italy
  • Ospedale Sacro Cuore-Don Calabria U.O.C. Oncologica Medica Negrar, Italy
View Trial Details
Completed

A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC)

NCT02240433

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Suita-shi, Japan
View Trial Details
Completed

LifePearl-Doxo Pharmacokinetic (PK) Study

NCT02548780

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations
  • Evgenidio Therapeftirio "Agia Trias" Athens, Greece
  • Hospital Clínic i provincial de Barcelona Barcelona, Spain
  • Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland
View Trial Details
Completed

The Second Multicenter Hemophilia Cohort Study

NCT00341705

Conditions
Acquired Immunodeficiency Syndrome, Adenocarcinoma, Blood Coagulation Disorders, +46 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • University of California, Davis Davis, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 48 locations
View Trial Details
Completed

Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC

NCT02774187

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Cancer Center Sun Yat-sen University Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
  • Guangzhou Twelfth People 's Hospita Guangzhou, Guangdong, China
  • The Kaiping Center's Hospital Kaiping, Guangdong, China
View Trial Details
Completed

Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC

NCT00908752

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Richard Finn, M.D. Los Angeles, California, United States
  • Sharp Clinical Oncology Research San Diego, California, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • Rhode Island Hospital Providence, Rhode Island, United States
View all 94 locations
View Trial Details

Related conditions